LD 267
Session - 129th Maine Legislature
LR 1517
Item 1
Bill Tracking, Additional Documents Chamber Status

An Act To Amend the Laws Governing the Practice of Pharmacy

Be it enacted by the People of the State of Maine as follows:

Sec. 1. 32 MRSA §13702-A, sub-§22,  as enacted by PL 2007, c. 402, Pt. DD, §2, is amended to read:

22. Pharmacist.  "Pharmacist" means an individual provider of health care services licensed by this State to engage in the practice of pharmacy.
A. "Chain pharmacist" means an individual who is engaged in the practice of pharmacy within a chain; that is, where there is a corporate grouping of 4 or more pharmacies.
B. "Hospital pharmacist" means an individual who is engaged in the practice of pharmacy in a hospital setting.
C. "Independent pharmacist" means an individual who is engaged in the practice of pharmacy in an independent pharmacy; that is, where there are fewer than 4 pharmacies under the same ownership.
D. "Qualified assistant pharmacist" means an individual licensed by this State as a qualified assistant apothecary, qualified assistant or assistant pharmacist, provided that the license is in full force and effect, except for the right to serve as a pharmacist in charge.

Sec. 2. 32 MRSA §13702-A, sub-§28,  as amended by PL 2017, c. 185, §1, is further amended to read:

28. Practice of pharmacy.  "Practice of pharmacy" means the provision of health care services that includes the interpretation and evaluation of prescription drug orders; the compounding, dispensing and labeling of drugs and devices, except labeling by a manufacturer, packer or distributor of nonprescription drugs and commercially packaged legend drugs and devices; the participation in drug selection and drug utilization reviews; the proper and safe storage of drugs and devices and the maintenance of proper records for these drugs and devices; the administration of vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, or successor organization, for administration to adults; the performance of collaborative drug therapy management; the responsibility for advising, when necessary or regulated, of therapeutic values, content, hazards and use of drugs and devices; the ordering and dispensing of over-the-counter nicotine replacement products approved by the United States Food and Drug Administration; and the offering or performing of those acts, services, operations or transactions necessary in the conduct, operation, management and control of a pharmacy.


This bill specifies that the practice of pharmacy is the provision of health care services.

Top of Page